A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...
The Brighterside of News on MSN1d
Gene discovery revolutionizes the detection and treatment of prostate cancerProstate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...
Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World Health Organization.
A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...
The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.
Do you consider the cancer measurements to be small, thus making the “observation only” protocol correct? — B.A. Dear B.A.: ...
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL. So, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback